185 related articles for article (PubMed ID: 2837848)
1. Treatment of cytomegalovirus infections in renal transplant recipients with 9-(1,3-dihydroxy-2-propoxymethyl) guanine.
Cantarovich M; Hiesse C; Lantz O; Fassi-Fihri S; Charpentier B; Fries D
Transplantation; 1988 Jun; 45(6):1139-41. PubMed ID: 2837848
[No Abstract] [Full Text] [Related]
2. Successful treatment of cytomegalovirus disease with 9-(1,3-dihydroxy-2-propoxymethyl guanine).
de Hemptinne B; Lamy ME; Salizzoni M; Cornu C; Mostin J; Fevery J; De Groote V; Otte JB
Transplant Proc; 1988 Feb; 20(1 Suppl 1):652-5. PubMed ID: 2831645
[No Abstract] [Full Text] [Related]
3. Massive cytomegalovirus pneumonia and myocarditis in a renal transplant recipient: successful treatment with DHPG.
Shabtai M; Luft B; Waltzer WC; Anaise D; Rapaport FT
Transplant Proc; 1988 Jun; 20(3):562-3. PubMed ID: 2837853
[No Abstract] [Full Text] [Related]
4. DHPG treatment of kidney transplant recipients with severe CMV infection.
Lang P; Buisson C; Rostoker G; Ben Maadi A; Fruchaud G; Deforge L; Chopin D; Abbou C; Romano P; Fleury J
Transplant Proc; 1989 Feb; 21(1 Pt 2):2084-6. PubMed ID: 2540560
[No Abstract] [Full Text] [Related]
5. Tolerance and efficacy of ganciclovir in the treatment of cytomegalovirus infections in immunosuppressed patients.
Ho WG; Winston DJ; Champlin RE
Transplant Proc; 1989 Feb; 21(1 Pt 3):3103-6. PubMed ID: 2539690
[No Abstract] [Full Text] [Related]
6. Treatment of cytomegalovirus gastrointestinal ulceration in a heart transplant patient.
Sinnott JT; Cullison JP; Rogers K
J Heart Transplant; 1987; 6(3):186-8. PubMed ID: 2821210
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir.
Verdonck LF; de Gast GC; Dekker AW; de Weger RA; Schuurman HJ; Rozenberg-Arska M
Bone Marrow Transplant; 1989 Mar; 4(2):187-9. PubMed ID: 2539877
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cytomegalovirus pneumonia in heart transplant recipients with 9(1,3-dihydroxy-2-proproxymethyl)-guanine (DHPG).
Watson FS; O'Connell JB; Amber IJ; Renlund DG; Classen D; Johnston JM; Smith CB; Bristow MR
J Heart Transplant; 1988; 7(2):102-5. PubMed ID: 2835468
[TBL] [Abstract][Full Text] [Related]
9. Ganciclovir in the treatment of cytomegalovirus pneumonitis in bone marrow transplant recipients.
Milliken S; Powles R; Ettinger N; Gallagher C; Jameson B; Tryhorn Y; Stern H; Selby P
Transplant Proc; 1989 Feb; 21(1 Pt 3):3110-1. PubMed ID: 2539692
[No Abstract] [Full Text] [Related]
10. Life-threatening cytomegalovirus infection treated with dihydropropoxymethylguanine.
Creasy TS; Flower AJ; Veitch PS
Lancet; 1986 Mar; 1(8482):675. PubMed ID: 2869359
[No Abstract] [Full Text] [Related]
11. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
[TBL] [Abstract][Full Text] [Related]
12. Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients.
Schmidt GM; Kovacs A; Zaia JA; Horak DA; Blume KG; Nademanee AP; O'Donnell MR; Snyder DS; Forman SJ
Transplantation; 1988 Dec; 46(6):905-7. PubMed ID: 2849818
[No Abstract] [Full Text] [Related]
13. [Treatment of cytomegalovirus retinitis with dihydroxypropoxymethylguanine in a patient with acquired immunodeficiency syndrome].
Guelar A; Grau J; Buil JA; Castilla M
Med Clin (Barc); 1987 Oct; 89(10):439-40. PubMed ID: 2824940
[No Abstract] [Full Text] [Related]
14. A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients.
Pavlopoulou ID; Syriopoulou VP; Chelioti H; Daikos GL; Stamatiades D; Kostakis A; Boletis JN
Clin Microbiol Infect; 2005 Sep; 11(9):736-43. PubMed ID: 16104989
[TBL] [Abstract][Full Text] [Related]
15. Ganciclovir and hyperimmunoglobulin for treating cytomegalovirus infection in bone marrow transplant recipients.
Aulitzky WE; Tilg H; Niederwieser D; Hackl M; Meister B; Huber C
J Infect Dis; 1988 Aug; 158(2):488-9. PubMed ID: 2841384
[No Abstract] [Full Text] [Related]
16. DHPG (Gancyclovir) improves survival in CMV pneumonia.
Mai M; Nery J; Sutker W; Husberg B; Klintmalm G; Gonwa T
Transplant Proc; 1989 Feb; 21(1 Pt 2):2263-5. PubMed ID: 2540565
[No Abstract] [Full Text] [Related]
17. [Ganciclovir and infections caused by the cytomegalic inclusion virus].
Roy C
Med Clin (Barc); 1989 Feb; 92(6):220-2. PubMed ID: 2540386
[No Abstract] [Full Text] [Related]
18. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.
Erice A; Jordan MC; Chace BA; Fletcher C; Chinnock BJ; Balfour HH
JAMA; 1987 Jun; 257(22):3082-7. PubMed ID: 3035246
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of severe cytomegalovirus infections with ganciclovir and CMV hyperimmune globulin in liver transplant recipients.
D'Alessandro AM; Pirsch JD; Stratta RJ; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1989 Jun; 21(3):3560-1. PubMed ID: 2545018
[No Abstract] [Full Text] [Related]
20. Resolution of oral hairy leukoplakia during therapy with 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).
Newman C; Polk BF
Ann Intern Med; 1987 Sep; 107(3):348-50. PubMed ID: 3039887
[No Abstract] [Full Text] [Related]
[Next] [New Search]
